title: Possible involvement of the antiserotoninergic and antihistaminergic activity in the anticataleptogenic effect of EGYT-2509.
authors.affiliation: EGIS Pharmaceuticals, Division of Pharmacology, Budapest.
authors.forename: G
authors.initials: G
authors.lastname: István
authors.forename: I
authors.initials: I
authors.lastname: Gyertyán
authors.forename: G
authors.initials: G
authors.lastname: Gigler
authors.forename: E
authors.initials: E
authors.lastname: Somogyi
authors.forename: L
authors.initials: L
authors.lastname: Petöcz
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000037:antagonists & inhibitors; D002375:Catalepsy / Q000139:chemically induced / Q000517:prevention & control*; D003989:Dibenzoxazepines / Q000494:pharmacology*; D006633:Histamine Antagonists; D010095:Oxotremorine / Q000037:antagonists & inhibitors; D051381:Rats; D012702:Serotonin Antagonists; D014202:Tremor / Q000139:chemically induced / Q000517:prevention & control
chemical_list: D014150:Antipsychotic Agents; D003989:Dibenzoxazepines; D006633:Histamine Antagonists; D012702:Serotonin Antagonists; D010095:Oxotremorine; C049176:EGYT 2509